LTIMindtree’s share price is in focus on Wednesday as brokerages remain largely optimistic about its long-term growth trajectory, backed by strong deal momentum and an ambitious plan to double revenue by FY31. Firms like Centrum and Emkay see significant upside potential, driven by large deal wins and an accelerating shift toward AI-led transformation. However, Morgan Stanley has sounded a note of caution, highlighting near-term revenue compression risks from rapid AI adoption, even as it expands the company’s long-term addressable market.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)
